Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 9 of 15
Mesenbio
DSW Ventures
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Mestag Therapeutics
SV7 Impact Medicine Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2021
Hold
5yr
MicroHarvest
Simon Capital Evergreen
Sector
Biotech
InvestorSimon Capital
Entry
2023
Hold
3yr
Micthera
Indaco BIO
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2024
Hold
2yr
MinervaX
Wellington Partners Life Sciences
Sector
Biotech
InvestorWellington Partners
Entry
2020
Hold
6yr
mo:re
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2025
Hold
1yr
Modern Meadow
Evonik Venture Capital
Sector
Biotech
InvestorEvonik Venture Capital
Entry
2019
Hold
7yr
Montis Biosciences
ALSA Ventures European Biotechnology Fund
Sector
Biotech
InvestorALSA Ventures
Entry
2020
Hold
6yr
Mosaic TX
CIC Fund II
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2023
Hold
3yr
Mosanna
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
multimmune
S-Refit AG
Sector
Biotech
InvestorSobera Capital
Entry
2016
Hold
10yr
Multiomic Health
MMC Ventures EIS Fund
Sector
Biotech
InvestorMMC Ventures
Entry
2023
Hold
3yr
Mytos
IQ Capital Fund IV
Sector
Biotech
InvestorIQ Capital Partners
Entry
2023
Hold
3yr
Nanological
Clave Innohealth FCR
Sector
Biotech
InvestorClave Mayor
Entry
2023
Hold
3yr
Navan
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2019
Hold
7yr
NeoVacs
Odyssee Venture Funds
Sector
Biotech
InvestorOdyssée Venture
Entry
–
Nested Therapeutics
TVM Life Science Ventures
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2022
Hold
4yr
NEUmiRNA
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2024
Hold
2yr
Neumirna Therapeutics
Invivo Ventures III
Sector
Biotech
InvestorInvivo Partners
Entry
2025
Hold
1yr
Neurona Therapeutics
Ysios BioFund III
Sector
Biotech
InvestorYsios Capital Partners
Entry
2024
Hold
2yr
NextPoint Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2023
Hold
3yr
Northsea Therapeutics
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2021
Hold
5yr
Nostos Genomics
42CAP II
Sector
Biotech
Investor42CAP
Entry
2022
Hold
4yr
Novogaia
Backed Fund III
Sector
Biotech
InvestorBACKED VC
Entry
2026
Hold
0yr
Nucaps
UN I+D+i Technology Transfer FCR
Sector
Biotech
InvestorClave Mayor
Entry
2017
Hold
9yr
Nucleome Therapeutics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2019
Hold
7yr
Nuntius Therapeutics
Backed Fund II
Sector
Biotech
InvestorBACKED VC
Entry
2021
Hold
5yr
Obulytix
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Ochre-Bio
Backed Fund II
Sector
Biotech
InvestorBACKED VC
Entry
2020
Hold
6yr
Oloker Therapeutics
Siryo S.p.A.
Sector
Biotech
InvestorSiryo
Entry
2021
Hold
5yr
OMass Therapeutics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
10yr
OMEICOS
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2013
Hold
13yr
Omeicos Therapeutics
VC Fonds Technologie Berlin
Sector
Biotech
InvestorIBB Ventures
Entry
2014
Hold
12yr
Oncostellae
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2015
Hold
11yr
Oncostellae, S.L.
SODIGA Galicia
Sector
Biotech
InvestorXesGalicia
Entry
2017
Hold
9yr
OneChain Immunotherapeutics
Invivo Ventures
Sector
Biotech
InvestorInvivo Partners
Entry
2023
Hold
3yr
OneChain Therapeutics
Nara Health Capital
Sector
Biotech
InvestorNara Capital Partners
Entry
2023
Hold
3yr
Orbit Discovery
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
10yr
Ori Biotech
Amadeus IV Digital Prosperity Fund
Sector
Biotech
InvestorAmadeus Capital Partners
Entry
2020
Hold
6yr
Oryzon
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2017
Hold
9yr
Outpost Bio
Merantix Capital AI Fund
Sector
Biotech
InvestorMerantix Capital
Entry
2025
Hold
1yr
OxThera
Ysios BioFund II Innvierte
SE
Sector
Biotech
InvestorYsios Capital Partners
Entry
2016
Hold
10yr
Palveera
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
PAM Theragnostics GmbH
Fruehphasen- und Wachstumsfonds Brandenburg
Sector
Biotech
InvestorBrandenburg Kapital
Entry
2021
Hold
5yr
Paratus Sciences
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2023
Hold
3yr
PerFormS
Utopia SIS
Sector
Biotech
InvestorUtopia SIS
Entry
2022
Hold
4yr
PerioTrap Pharmaceuticals
IBG Innovationsfonds
Sector
Biotech
Investorbmp Ventures AG
Entry
2020
Hold
6yr
PharmEnable
Parkwalk Opportunities EIS Fund
Sector
Biotech
InvestorParkwalk Advisors
Entry
2020
Hold
6yr
Pheno Therapeutics
LifeArc Ventures
Sector
Biotech
InvestorLifeArc
Entry
2020
Hold
6yr
Phialogics
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2022
Hold
4yr